SS Innovations International Inc
OTC:SSII

Watchlist Manager
SS Innovations International Inc Logo
SS Innovations International Inc
OTC:SSII
Watchlist
Price: 5.355 USD -2.99% Market Closed
Market Cap: $1B

Relative Value

There is not enough data to reliably calculate the relative value of SSII.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SSII Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

SSII Competitors Multiples
SS Innovations International Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
SS Innovations International Inc
OTC:SSII
1B USD 63.3 -37.3 -38.6 -38.3
US
Abbott Laboratories
NYSE:ABT
189.1B USD 4.3 29 16.5 22.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
190.1B USD 18.9 66.6 51 61.7
US
Boston Scientific Corp
NYSE:BSX
138.7B USD 7.2 49.8 29.1 39.6
US
Stryker Corp
NYSE:SYK
136.1B USD 5.6 46.3 22.6 27.4
IE
Medtronic PLC
NYSE:MDT
130.6B USD 3.8 27.4 15.4 22.2
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD 2.7 34.6 12.7 21.6
DE
Siemens Healthineers AG
XETRA:SHL
48.5B EUR 2.1 22.6 12.8 18.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56B USD 13.4 54.4 39.1 43.3
US
Edwards Lifesciences Corp
NYSE:EW
48.9B USD 8.3 35.7 25.5 28
US
Resmed Inc
NYSE:RMD
37.3B USD 7.1 26 18.6 20.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
SS Innovations International Inc
OTC:SSII
Average EV/EBITDA: 24.3
Negative Multiple: -38.6
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
51
24%
2.1
US
Boston Scientific Corp
NYSE:BSX
29.1
22%
1.3
US
Stryker Corp
NYSE:SYK
22.6
13%
1.7
IE
Medtronic PLC
NYSE:MDT
15.4
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.8
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.1
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
25.5
13%
2
US
Resmed Inc
NYSE:RMD
18.6
11%
1.7